search
Back to results

Impact of Behavioral Treatment of Insomnia on Nighttime Urine Production

Primary Purpose

Sleep Fragmentation, Poor Quality Sleep, Nocturia

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Brief behavioral treatment of insomnia (BBTI)
Information-only control (IC)
Sponsored by
University of Pittsburgh
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Sleep Fragmentation focused on measuring Nocturia, Poor sleep

Eligibility Criteria

65 Years - undefined (Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • ambulatory and functionally-independent community-dwelling men and women
  • aged 65 years, or more
  • with nocturia ≥2/night
  • poor sleep because of frequent awakenings

Exclusion Criteria:

  • Unstable or acute medical or central nervous system conditions
  • Untreated, current, severe psychiatric condition
  • Untreated, current, severe overactive bladder syndrome
  • Post void residual > 30ml
  • Sleep apnea with AHI≥15
  • Currently diagnosed and/or treated Obstructive Sleep Apnea, Restless Legs Syndrome, parasomnia
  • Congestive heart failure, by exam or Beta natriuretic peptide (BNP)> 30 pmol/L
  • Chronic kidney disease, stage III-V (eGFR<50)
  • >14 alcohol drinks per week

Sites / Locations

  • University of Pittsburgh

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

Brief behavioral treatment for insomnia

Information-only control

Arm Description

This group will undergo behavioral intervention proven to improve sleep among older adults: brief behavioral treatment for insomnia

This group is called information-only control. They will be provided sleep-related information. They will also view a video content of which overlap substantially with BBTI but without individualized behavioral instructions.

Outcomes

Primary Outcome Measures

Change in Nocturnal Polyuria Index
Nocturnal Polyuria Index (NPI) is the percentage of 24-hour urine production excreted at night. It is measured using 3-day bladder diary that participants will complete pre- and post-intervention in which the participants document the time and volume of each void during the day and night for 3 days. NPI is calculated using a) nocturnal urine volume (determined by adding the volume of all voids between the times marked in the bladder diary as going to bed with the intent of sleeping and the first awakening to void. The first void after waking is included in the nighttime urine volume), and b) 24-hour urine volume. NPI is calculated as: nocturnal urine volume /24-hour urine volume

Secondary Outcome Measures

Change in Nocturia
Nocturia=number of awakenings to void each night
Change in Duration of Uninterrupted Sleep
Duration of uninterrupted sleep is the first uninterrupted sleep period before first awakening to void

Full Information

First Posted
March 12, 2019
Last Updated
November 25, 2022
Sponsor
University of Pittsburgh
Collaborators
National Institute on Aging (NIA)
search

1. Study Identification

Unique Protocol Identification Number
NCT03883724
Brief Title
Impact of Behavioral Treatment of Insomnia on Nighttime Urine Production
Official Title
Impact of Behavioral Treatment of Insomnia on Nighttime Urine Production
Study Type
Interventional

2. Study Status

Record Verification Date
November 2022
Overall Recruitment Status
Completed
Study Start Date
February 1, 2019 (Actual)
Primary Completion Date
November 30, 2021 (Actual)
Study Completion Date
November 30, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Pittsburgh
Collaborators
National Institute on Aging (NIA)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Nocturia is prevalent in older adults and it vastly reduces quality of life. Yet its treatment remains inadequate because its causes are not well understood, especially nocturnal polyuria or increased urine production at night. This study, which builds on the investigators' ongoing research, would be the first of its kind to explore the role of sleep in nighttime urine production. The findings will contribute important knowledge to guide development of better targeted and more effective therapy for this prevalent and morbid condition.
Detailed Description
Prevalent, morbid, and costly ($61 billion/year in 2012), nocturia is a major problem, especially for older adults. It increases the risk of falls, fractures, depression, nursing home placement, and death. Yet management of nocturia remains inadequate. Most behavior and pharmacotherapies for nocturia focus on bladder-related etiologies, and it's most prevalent attribute nocturnal polyuria (NP), or increased urine production during sleep remains poorly understood and inadequately treated with little advancement over the last 50 years. Disruption of diurnal excretory pattern, with higher nighttime urine production is common in older adults. While studies in young adults show that sleep plays a critical role in regulating nighttime urine production, among older adults the role of poor sleep in NP is under-investigated. Urine production follows a circadian pattern in which transition from wake to sleep is followed by a pronounced decrease in excretion of water, electrolytes and other osmotically active substances. Studies in young population have established that physiological urine production follows a circadian rhythm, which is regulated by diurnal variation in secretion of hormones controlling water and salt excretion such as arginine vasopressin, renin-angiotensin-aldosterone system, and atrial natriuretic peptide. Sleep deprivation blunts nocturnal surge of these hormones and consequently alter water and salt excretion thereby increase nighttime urine volume leading to NP. Recent evidence suggests that poor sleep quality, frequent sleep interruptions especially in the first part of the night and shorter duration of first uninterrupted sleep period are associated with NP but its pathophysiology is not fully understood. Additionally, among older adults with poor sleep, the investigators have shown that a behavioral intervention directed solely towards sleep (BBTI- brief behavioral treatment of insomnia an efficacious multimodal behavioral treatment for insomnia) not only improves sleep, but also nocturia. Hence, the investigators postulate that sleep interruptions in the first part of the sleep impacts the hormonal regulation of nighttime urine production causing NP. In addition, the investigators postulate that interventions to prolong the first uninterrupted sleep period will decrease NP and hence nocturia. The, aims of the present proposal are to: 1) examine the impact of BBTI on duration of the first of uninterrupted sleep period and NP in elderly with nocturia; and 2) establish NP and duration of first uninterrupted sleep as mechanisms by which BBTI impacts nocturia. The investigators' hypothesis is that BBTI improves nocturia not only by improving sleep, (and specifically, duration of the first uninterrupted sleep period), but also by decreasing NP. To accomplish these goals the investigators will recruit 60 community dwelling adults (aged >65) with nocturia and NP. Sleep will be assessed subjectively with the Insomnia Severity Index and objectively by 7-day sleep diary and wrist actigraph. Concurrently the investigators will collect 3-day bladder diary data to document their voiding pattern and volume during day and night. Participants will be randomized to receive the 4-week behavioral sleep intervention BBTI by a trained therapist or an information control intervention. The participants will repeat the study measures post-intervention. The study results will provide important insights into shared pathological mechanisms underlying poor sleep, nocturia and nighttime urine production.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sleep Fragmentation, Poor Quality Sleep, Nocturia, Nocturnal Enuresis
Keywords
Nocturia, Poor sleep

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized controlled trial
Masking
None (Open Label)
Allocation
Randomized
Enrollment
56 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Brief behavioral treatment for insomnia
Arm Type
Experimental
Arm Description
This group will undergo behavioral intervention proven to improve sleep among older adults: brief behavioral treatment for insomnia
Arm Title
Information-only control
Arm Type
Other
Arm Description
This group is called information-only control. They will be provided sleep-related information. They will also view a video content of which overlap substantially with BBTI but without individualized behavioral instructions.
Intervention Type
Behavioral
Intervention Name(s)
Brief behavioral treatment of insomnia (BBTI)
Intervention Description
The BBTI consists of a 45- to 60-minute individual intervention session followed by a 30-minute follow-up session 2 weeks later and 20-minute telephone calls after 1 and 3 weeks. The brief behavioral treatment component will focus on four behaviors that promote sleep through homeostatic, circadian, or association mechanisms. 50 These four interventions are simple to conceptualize and implement, and constitute the core of efficacious multi-modal behavioral treatments for insomnia.
Intervention Type
Behavioral
Intervention Name(s)
Information-only control (IC)
Intervention Description
The IC condition is intended to emulate the behavioral treatment information generally to available patients. It includes instructions to review hand out on healthy sleep practices. We will also use patient education videos on insomnia developed locally and widely used in clinical research. The content of these videos overlap substantially with BBTI but without individualized behavioral instructions. Two weeks later, IC participants will receive a 10-minute follow-up telephone call to encourage continued participation. Participants will be referred to the brochures for specific sleep-related questions.
Primary Outcome Measure Information:
Title
Change in Nocturnal Polyuria Index
Description
Nocturnal Polyuria Index (NPI) is the percentage of 24-hour urine production excreted at night. It is measured using 3-day bladder diary that participants will complete pre- and post-intervention in which the participants document the time and volume of each void during the day and night for 3 days. NPI is calculated using a) nocturnal urine volume (determined by adding the volume of all voids between the times marked in the bladder diary as going to bed with the intent of sleeping and the first awakening to void. The first void after waking is included in the nighttime urine volume), and b) 24-hour urine volume. NPI is calculated as: nocturnal urine volume /24-hour urine volume
Time Frame
change from baseline nocturnal polyuria index at 4 weeks
Secondary Outcome Measure Information:
Title
Change in Nocturia
Description
Nocturia=number of awakenings to void each night
Time Frame
change from baseline nocturia episodes each night at 4 weeks
Title
Change in Duration of Uninterrupted Sleep
Description
Duration of uninterrupted sleep is the first uninterrupted sleep period before first awakening to void
Time Frame
Change from baseline duration of uninterrupted sleep at 4 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: ambulatory and functionally-independent community-dwelling men and women aged 65 years, or more with nocturia ≥2/night poor sleep because of frequent awakenings Exclusion Criteria: Unstable or acute medical or central nervous system conditions Untreated, current, severe psychiatric condition Untreated, current, severe overactive bladder syndrome Post void residual > 30ml Sleep apnea with AHI≥15 Currently diagnosed and/or treated Obstructive Sleep Apnea, Restless Legs Syndrome, parasomnia Congestive heart failure, by exam or Beta natriuretic peptide (BNP)> 30 pmol/L Chronic kidney disease, stage III-V (eGFR<50) >14 alcohol drinks per week
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Shachi Tyagi, MD, MS
Organizational Affiliation
University of Pittsburgh
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Pittsburgh
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15213
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Impact of Behavioral Treatment of Insomnia on Nighttime Urine Production

We'll reach out to this number within 24 hrs